HCA Healthcare Inc. (HCA) Social Stream
HCA HEALTHCARE INC (HCA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering HCA HEALTHCARE INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-26 | 17 | $320 | $222 | $287.176 | $250.66 | 14.57% |
| 2021-12-21 | 17 | $320 | $222 | $287.176 | $250.66 | 14.57% |
| 2022-01-03 | 17 | $320 | $222 | $288.058 | $250.66 | 14.92% |
| 2022-01-05 | 17 | $320 | $222 | $290.411 | $250.66 | 15.86% |
| 2022-01-20 | 17 | $320 | $222 | $292.294 | $250.66 | 16.61% |
| 2022-01-28 | 17 | $320 | $222 | $290.117 | $250.66 | 15.74% |
| 2022-01-31 | 17 | $312 | $222 | $289.176 | $250.66 | 15.37% |
| 2022-02-08 | 17 | $312 | $222 | $288.411 | $250.66 | 15.06% |
| 2022-03-24 | 17 | $312 | $222 | $287.823 | $250.66 | 14.83% |
| 2022-04-01 | 18 | $312 | $222 | $286.666 | $250.66 | 14.36% |
| 2022-04-13 | 17 | $312 | $222 | $286.47 | $250.66 | 14.29% |
| 2022-04-22 | 16 | $312 | $222 | $286.47 | $250.66 | 14.29% |
| 2022-04-25 | 14 | $312 | $222 | $285.058 | $250.66 | 13.72% |
| 2022-04-26 | 15 | $312 | $241 | $280.187 | $250.66 | 11.78% |
| 2022-04-27 | 15 | $306 | $240 | $271.882 | $250.66 | 8.47% |
| 2022-05-11 | 15 | $306 | $235 | $265.705 | $250.66 | 6% |
| 2022-05-26 | 16 | $306 | $235 | $263.058 | $250.66 | 4.95% |
| 2022-05-27 | 16 | $306 | $235 | $263.5 | $250.66 | 5.12% |
| 2022-06-17 | 18 | $306 | $235 | $260.421 | $250.66 | 3.89% |
| 2022-06-21 | 18 | $306 | $235 | $258.578 | $250.66 | 3.16% |
| 2022-07-27 | 20 | $275 | $160 | $240.3 | $250.66 | -4.13% |
| 2022-07-28 | 20 | $275 | $160 | $236.9 | $250.66 | -5.49% |
| 2022-08-01 | 20 | $275 | $160 | $236.15 | $250.66 | -5.79% |
| 2022-08-10 | 20 | $275 | $160 | $237.15 | $250.66 | -5.39% |
| 2022-08-13 | 19 | $275 | $160 | $235.578 | $250.66 | -6.02% |
| 2022-08-18 | 19 | $275 | $160 | $236.789 | $250.66 | -5.53% |
| 2022-09-13 | 19 | $275 | $160 | $237.789 | $250.66 | -5.13% |
| 2022-09-17 | 19 | $275 | $160 | $238.842 | $250.66 | -4.71% |
| 2022-10-24 | 18 | $275 | $160 | $238.473 | $250.66 | -4.86% |
| 2022-10-25 | 18 | $275 | $160 | $237.421 | $250.66 | -5.28% |
| 2022-10-26 | 18 | $275 | $160 | $235.526 | $250.66 | -6.04% |
| 2022-11-01 | 18 | $275 | $160 | $236.105 | $250.66 | -5.81% |
| 2022-11-02 | 18 | $275 | $160 | $236.736 | $250.66 | -5.55% |
| 2022-11-18 | 18 | $275 | $160 | $237.894 | $250.66 | -5.09% |
| 2022-12-12 | 18 | $275 | $160 | $239.579 | $250.66 | -4.42% |
| 2022-12-16 | 18 | $286 | $160 | $242.368 | $250.66 | -3.31% |
| 2023-01-03 | 18 | $286 | $160 | $246.526 | $250.66 | -1.65% |
| 2023-01-05 | 18 | $286 | $160 | $249.684 | $250.66 | -0.39% |
| 2023-01-09 | 19 | $294 | $160 | $250.421 | $250.66 | -0.1% |
| 2023-01-13 | 19 | $296 | $160 | $253.315 | $250.66 | 1.06% |
| 2023-01-27 | 19 | $296 | $160 | $255.157 | $250.66 | 1.79% |
| 2023-01-30 | 19 | $296 | $160 | $258 | $250.66 | 2.93% |
| 2023-01-31 | 19 | $300 | $160 | $270.631 | $250.66 | 7.97% |
| 2023-02-08 | 19 | $300 | $160 | $272.473 | $250.66 | 8.7% |
| 2023-02-21 | 19 | $300 | $160 | $274.105 | $250.66 | 9.35% |
| 2023-02-23 | 19 | $300 | $160 | $275.421 | $250.66 | 9.88% |
| 2023-03-13 | 19 | $300 | $160 | $276.736 | $250.66 | 10.4% |
The Trend in the Analyst Price Target
HCA's average price target has moved down $11.09 over the prior 51 weeks.
Over the past 51 weeks, HCA's average upside potential has been 14.55%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-27 | 15 | 306 | 235 | 269.823 | 212.23 | 27.14% |
| 2022-05-26 | 16 | 306 | 235 | 263.058 | 211.79 | 24.21% |
| 2023-01-09 | 19 | 294 | 160 | 250.421 | 249.79 | 0.25% |
| 2023-02-21 | 19 | 300 | 160 | 274.105 | 256.09 | 7.03% |
| 2023-02-23 | 19 | 300 | 160 | 276.736 | 251.98 | 9.82% |
HCA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.42 | 15 | 2 | 1 | 1 | 1 | 19 |
The Trend in the Broker Recommendations
HCA's average broker recommendation rating improved by 0.54 over the prior 20 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- HCA HEALTHCARE INC's average analyst price target is higher than 5396.08% of all US stocks.
- HCA HEALTHCARE INC's number of analysts covering the stock is higher than 5462.61% of Healthcare stocks.
- In terms of how HCA HEALTHCARE INC fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is greater than 534.73% of that group.
- To contextualize these metrics, consider that out of stocks in the large market cap category, HCA HEALTHCARE INC's variance in analysts' estimates is lower than -2477.34% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Healthcare industry with the ratings most similar to HCA HEALTHCARE INC are UHS, THC, and FMS.
View All Top Stocks by Price Target
Make investment decisions regarding HCA using the data that counts. Try POWR Ratings for free.